Satsuma Pharmaceuticals Inc
Biotechnology
Healthcare
STSA
31.55 M shares
NASDAQ US
traded
11 Nov 2022
listed
yes
open
4.12
52 week high
7.95
high
4.28
52 week low
2.59
low
4.01
growth
-25.00 %
previous Close
4.23
P/E ratio
market cap
189 M
div yield
0
usd
Jun 2022
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
-6.12 %
eps surprise
-6.12 %
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top